Ginkgo Bioworks

What is Ginkgo Bioworks?

Ginkgo Bioworks is a company within the Biotechnology category. Ginkgo Bioworks is a synthetic biology company that designs and builds custom microbes for customers across various industries, including agriculture, pharmaceuticals, and industrial chemicals. The company operates high-throughput automated 'foundries' to program cells as if they were software, utilizing a vast proprietary codebase of biological parts.

When was Ginkgo Bioworks founded and where is it based?

Ginkgo Bioworks was founded in 2008 and is headquartered in Boston, MA.

Is Ginkgo Bioworks part of a parent company?

Ginkgo Bioworks is part of Independent.

What is Ginkgo Bioworks's Brand Authority Index tier?

Ginkgo Bioworks is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.

How accurately do AI models describe Ginkgo Bioworks?

AI narrative accuracy for Ginkgo Bioworks is Strong. Significant factual deltas detected.

How do AI models position Ginkgo Bioworks competitively?

AI models classify Ginkgo Bioworks as a Challenger. AI names competitors first.

How visible is Ginkgo Bioworks in buyer-intent AI queries?

Ginkgo Bioworks appeared in 7 of 8 sampled buyer-intent queries (88%). Ginkgo dominates queries related to 'cell programming' and 'foundries' but faces stiff competition in broader 'biosecurity' and 'generative AI for biology' queries where tech-first companies also play.

What do AI models currently say about Ginkgo Bioworks?

AI reliably describes the company as the 'Microsoft of Biology' due to its platform-centric approach. However, it often struggles to provide real-time updates on its shifting revenue mix between R&D services and biosecurity monitoring. Key gap: The distinction between their core synthetic biology platform (R&D) and their significant biosecurity revenue (Concentric) is often blurred, leading to confusion about their primary business drivers.

How many facts about Ginkgo Bioworks are well-documented vs need fixing vs retrieval-dependent?

Of 5 key facts verified about Ginkgo Bioworks, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.

What is Ginkgo Bioworks's biggest AI narrative vulnerability?

Financial sustainability and path to profitability are frequently cited with outdated figures as the brand's financial health changes rapidly between quarterly reports.

What problems does Ginkgo Bioworks solve for buyers?

Buyers turn to Ginkgo Bioworks for In-house R&D Team: Hiring PhD-level biologists and lab technicians to manually design, build, and test organisms using traditional lab equipment., Traditional CROs: Outsourcing specific bioengineering tasks to traditional Contract Research Organizations (CROs) that lack high-throughput automation., among 2 documented problem areas.

What questions do buyers ask AI about Ginkgo Bioworks?

Buyers evaluating Ginkgo Bioworks typically ask AI models about "cell programming platform", "synthetic biology foundries", "organism engineering services", and 4 similar queries.

Who are Ginkgo Bioworks's main competitors?

Ginkgo Bioworks's main competitors are Absci, Zymergen. According to AI models, these are the brands most frequently named alongside Ginkgo Bioworks in buyer-intent queries.

What does Ginkgo Bioworks offer?

Ginkgo Bioworks's core products are Cell programming, Protein expression, Strain engineering, Biosecurity monitoring (Concentric), Biological codebase access..

How is Ginkgo Bioworks priced?

Ginkgo Bioworks uses Enterprise/Custom (Platform fees + Milestones/Royalties).

Who does Ginkgo Bioworks target?

Ginkgo Bioworks serves Agriculture, Pharmaceuticals, Food & Nutrition, Industrial Chemicals, Government/Public Health..

What differentiates Ginkgo Bioworks from competitors?

Ginkgo Bioworks Operates the world's most advanced automated biological 'foundries' combined with a massive proprietary codebase for rapid organism design.

Verified from Ginkgo Bioworks website

Founded: 2008

Headquarters: Boston, Massachusetts, USA

Competitors

• Absci
• Zymergen

Also Referenced By

• Genomatica (Geno)
• Amyris, Inc.

Problems this brand solves

• In-house R&D Team: Hiring PhD-level biologists and lab technicians to manually design, build, and test organisms using traditional lab equipment.
• Traditional CROs: Outsourcing specific bioengineering tasks to traditional Contract Research Organizations (CROs) that lack high-throughput automation.

Buyers search for

• cell programming platform
• synthetic biology foundries
• organism engineering services
• biological codebase providers
• generative ai for protein design agents
• biosecurity monitoring infrastructure
• Off-the-shelf Simulation Software: Attempting to optimize chemical or biological processes using existing simulation software without the specialized organism-design platform.